2022 Q1 Form 10-K Financial Statement

#000156459022006702 Filed on February 24, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q4 2021
Revenue $11.99M $12.52M $75.44M
YoY Change -31.08% -31.98% 15.81%
Cost Of Revenue $2.284M $11.43M $36.96M
YoY Change -69.95% 81.49% 145.01%
Gross Profit $994.0K $1.081M $38.49M
YoY Change -89.86% -91.14% -23.12%
Gross Profit Margin 8.29% 8.64% 51.01%
Selling, General & Admin $20.70M $22.73M $77.42M
YoY Change 18.86% 32.91% 31.13%
% of Gross Profit 2082.19% 2102.41% 201.16%
Research & Development $3.536M $3.886M $12.31M
YoY Change 44.8% -73.74% 97.06%
% of Gross Profit 355.73% 359.48% 31.99%
Depreciation & Amortization $599.0K $1.220M $2.000M
YoY Change 30.22% 139.22% 11.11%
% of Gross Profit 60.26% 112.86% 5.2%
Operating Expenses $24.23M $26.61M $89.73M
YoY Change 22.05% -16.57% 37.44%
Operating Profit -$23.24M -$25.53M -$47.02M
YoY Change 131.12% 29.6% -1.86%
Interest Expense -$2.759M -$2.530M -$9.898M
YoY Change 6.12% -60.47% -42.79%
% of Operating Profit
Other Income/Expense, Net $0.00 $1.000K -$239.0K
YoY Change -100.0%
Pretax Income -$26.00M -$28.06M -$80.93M
YoY Change 101.29% 6.29% 40.84%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$26.00M -$28.06M -$80.93M
YoY Change 101.29% 6.29% 41.38%
Net Earnings / Revenue -216.79% -224.22% -107.27%
Basic Earnings Per Share -$0.10 -$0.32
Diluted Earnings Per Share -$103.2K -$111.8K -$324.7K
COMMON SHARES
Basic Shares Outstanding 251.8M 249.2M
Diluted Shares Outstanding 251.9M 249.2M

Balance Sheet

Concept 2022 Q1 2021 Q4 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.4M $204.1M $204.1M
YoY Change -41.31% 204.65% 204.65%
Cash & Equivalents $67.24M $124.2M $124.2M
Short-Term Investments $95.20M $79.93M $79.93M
Other Short-Term Assets $3.952M $3.482M $3.482M
YoY Change 31.73% 5.52% 5.52%
Inventory $8.044M $7.152M $7.152M
Prepaid Expenses
Receivables $9.823M $4.739M $4.994M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $184.3M $219.7M $219.7M
YoY Change -36.09% 176.49% 176.41%
LONG-TERM ASSETS
Property, Plant & Equipment $41.45M $36.61M $36.61M
YoY Change 56.39% 41.54% 41.36%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $70.54M $56.62M $56.62M
YoY Change 4602.8%
Other Assets $12.06M $8.186M $8.186M
YoY Change 288.97% 150.72% 148.06%
Total Long-Term Assets $124.1M $101.4M $101.4M
YoY Change 298.88% 248.13% 248.51%
TOTAL ASSETS
Total Short-Term Assets $184.3M $219.7M $219.7M
Total Long-Term Assets $124.1M $101.4M $101.4M
Total Assets $308.3M $321.2M $321.2M
YoY Change -3.47% 195.71% 195.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.702M $6.956M $6.956M
YoY Change 29.88% 24.61% 24.21%
Accrued Expenses $27.13M $27.42M $24.35M
YoY Change -1.65% 39.13% 39.15%
Deferred Revenue $827.0K
YoY Change -97.51%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.410M $6.977M $6.977M
YoY Change 100.21% 70.17% 70.17%
Total Short-Term Liabilities $53.49M $48.35M $48.35M
YoY Change -26.82% -34.4% -34.4%
LONG-TERM LIABILITIES
Long-Term Debt $375.1M $374.7M $374.7M
YoY Change 15.11% 217.03% 217.03%
Other Long-Term Liabilities $7.054M $4.950M $107.4M
YoY Change -92.5% -94.9% 10.64%
Total Long-Term Liabilities $7.054M $4.950M $482.2M
YoY Change -98.32% -97.7% 123.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $53.49M $48.35M $48.35M
Total Long-Term Liabilities $7.054M $4.950M $482.2M
Total Liabilities $540.4M $530.5M $530.5M
YoY Change 9.61% 83.55% 83.57%
SHAREHOLDERS EQUITY
Retained Earnings -$3.156B -$3.100B
YoY Change 1.81% 1.67%
Common Stock $2.921B
YoY Change 1.81%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$232.1M -$209.3M -$209.3M
YoY Change
Total Liabilities & Shareholders Equity $308.3M $321.2M $321.2M
YoY Change -3.47% 195.71% 195.73%

Cashflow Statement

Concept 2022 Q1 2021 Q4 2021
OPERATING ACTIVITIES
Net Income -$26.00M -$28.06M -$80.93M
YoY Change 101.29% 6.29% 41.38%
Depreciation, Depletion And Amortization $599.0K $1.220M $2.000M
YoY Change 30.22% 139.22% 11.11%
Cash From Operating Activities -$18.25M -$12.35M -$61.71M
YoY Change 43.34% -5468.26% 119.39%
INVESTING ACTIVITIES
Capital Expenditures $5.056M -$5.190M -$11.47M
YoY Change 418.03% 15.85% -1531.46%
Acquisitions
YoY Change
Other Investing Activities -$34.45M -$7.389M -$140.1M
YoY Change 13.17% -800.36%
Cash From Investing Activities -$39.51M -$12.58M -$151.5M
YoY Change 25.74% 180.78% -1095.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 813.0K 97.37M 270.3M
YoY Change -99.64% 420.97% 442.13%
NET CHANGE
Cash From Operating Activities -18.25M -12.35M -61.71M
Cash From Investing Activities -39.51M -12.58M -151.5M
Cash From Financing Activities 813.0K 97.37M 270.3M
Net Change In Cash -56.94M 72.44M 57.02M
YoY Change -131.49% 401.69% 54.36%
FREE CASH FLOW
Cash From Operating Activities -$18.25M -$12.35M -$61.71M
Capital Expenditures $5.056M -$5.190M -$11.47M
Free Cash Flow -$23.30M -$7.157M -$50.24M
YoY Change 70.02% -251.95% 73.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 us-gaap Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List
OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#OtherAssets
CY2021 mnkd Longterm Purchase Commitment Renewal Time Period
LongtermPurchaseCommitmentRenewalTimePeriod
P2Y
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0039
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.9383
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0152
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y5M12D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y9M25D
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P5Y6M29D
CY2021Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P19Y9M18D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M24D
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-218000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124184000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67005000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
158000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
79932000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4218000
CY2020Q4 us-gaap Inventory Net
InventoryNet
4973000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3122000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
79476000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25867000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
56619000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8186000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3265000
CY2021Q4 us-gaap Assets
Assets
321161000
CY2020Q4 us-gaap Assets
Assets
108608000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6956000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5582000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27419000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19707000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
6977000
CY2020Q4 mnkd Paycheck Protection Program Loan Current
PaycheckProtectionProgramLoanCurrent
4061000
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
827000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
33275000
CY2021Q4 mnkd Purchase Obligation Current
PurchaseObligationCurrent
6170000
CY2020Q4 mnkd Purchase Obligation Current
PurchaseObligationCurrent
11080000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
48349000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73705000
CY2021Q4 mnkd Promissory Notes Noncurrent
PromissoryNotesNoncurrent
18425000
CY2020Q4 mnkd Promissory Notes Noncurrent
PromissoryNotesNoncurrent
63027000
CY2021Q4 mnkd Credit Facility Noncurrent
CreditFacilityNoncurrent
38833000
CY2020Q4 mnkd Credit Facility Noncurrent
CreditFacilityNoncurrent
49335000
CY2021Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
223944000
CY2021Q4 mnkd Purchase Obligation Noncurrent
PurchaseObligationNoncurrent
76659000
CY2020Q4 mnkd Purchase Obligation Noncurrent
PurchaseObligationNoncurrent
84208000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1040000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1202000
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
19543000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1662000
CY2021Q4 mnkd Milestone Rights Liabilities Noncurrent
MilestoneRightsLiabilitiesNoncurrent
4838000
CY2020Q4 mnkd Milestone Rights Liabilities Noncurrent
MilestoneRightsLiabilitiesNoncurrent
5926000
CY2020Q4 us-gaap Senior Long Term Notes
SeniorLongTermNotes
5000000
CY2020Q4 mnkd Paycheck Protection Program Loan Noncurrent
PaycheckProtectionProgramLoanNoncurrent
812000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4950000
CY2021Q4 us-gaap Liabilities
Liabilities
530510000
CY2020Q4 us-gaap Liabilities
Liabilities
289027000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
251477562
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
251477562
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
242117089
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
242117089
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
2515000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2421000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2918205000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2866303000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3130069000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3049143000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-209349000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-180419000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
321161000
CY2021 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
38000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
108608000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
65144000
CY2020 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
13233000
CY2021 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
12312000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
77417000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
59040000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
106000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1889000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
6567000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-8006000
CY2021 mnkd Gain Loss On Purchase Commitments
GainLossOnPurchaseCommitments
-339000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
122464000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
113057000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-47022000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-47913000
CY2021 mnkd Interest Expense On Financing Liability
InterestExpenseOnFinancingLiability
1373000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
249244000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
222585000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-19000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-80926000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-57259000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-190526000
CY2020 mnkd Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
233000
CY2020 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
519000
CY2020 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
9250000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6511000
CY2020 mnkd Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
11600000
CY2020 mnkd Stock Issued During Period Value Market Price Stock Purchase Plan
StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
215000
CY2020 mnkd Adjustments To Additional Paid In Capital Issuance Of Warrants Pursuant To Credit Facility
AdjustmentsToAdditionalPaidInCapitalIssuanceOfWarrantsPursuantToCreditFacility
275000
CY2020 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-19000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-57240000
CY2021 mnkd Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures
StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures
-498000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1090000
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
10000000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
793000
CY2020 mnkd Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
-4751000
CY2021 mnkd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2135000
CY2020 mnkd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-1312000
CY2021 mnkd Increase Decrease In Accrued Interest On Promissory Notes
IncreaseDecreaseInAccruedInterestOnPromissoryNotes
4919000
CY2021 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
4950000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-61709000
CY2021 mnkd Adjustment To Additional Paid In Capital Premium On Convertible Note
AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote
22107000
CY2021 mnkd Stock Issued During Period Value Market Price Stock Purchase Plan
StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan
106000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-80926000
CY2020 us-gaap Profit Loss
ProfitLoss
-57240000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-17200000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-264000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
12200000
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4215000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2149000
CY2021 mnkd Interest On Milestone Payment
InterestOnMilestonePayment
3663000
CY2021 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
1902000
CY2020 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
496000
CY2021 mnkd Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
1598000
CY2020 mnkd Interest Expense On Promissory Notes
InterestExpenseOnPromissoryNotes
5148000
CY2021 mnkd Amortization Of Financing Liability
AmortizationOfFinancingLiability
1372000
CY2021 mnkd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1258000
CY2020 mnkd Operating Lease Right Of Use Asset Amortization
OperatingLeaseRightOfUseAssetAmortization
1177000
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
106000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1889000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
6567000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-8006000
CY2020 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
13233000
CY2020 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-19000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
776000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
705000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4081000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1314000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
360000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
154000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
138000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-227000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1374000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
8814000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3346000
CY2021 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-14567000
CY2020 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5910000
CY2021 mnkd Increase Decrease In Recognized Loss On Purchase Commitments
IncreaseDecreaseInRecognizedLossOnPurchaseCommitments
-5892000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-28128000
CY2021 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
196131000
CY2021 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
59060000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
801000
CY2021 mnkd Purchase Of Available For Sale Securities
PurchaseOfAvailableForSaleSecurities
3000000
CY2020 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
20000000
CY2020 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
3983000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-151537000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15216000
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
230000000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
7268000
CY2021 mnkd Proceeds From Sale Leaseback Transaction
ProceedsFromSaleLeasebackTransaction
102250000
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3120000
CY2021 mnkd Deposit For Sale Leaseback Transaction
DepositForSaleLeasebackTransaction
2000000
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
35051000
CY2021Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
288400000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3100000000
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
103733000
CY2021 mnkd Payment Of Credit Facility Prepayment Penalty
PaymentOfCreditFacilityPrepaymentPenalty
1000000
CY2021 mnkd Milestone Payments
MilestonePayments
5000000
CY2021 mnkd Payments Related To Employment Taxes For Share Based Compensation And Proceeds From Exercise Of Stock Options
PaymentsRelatedToEmploymentTaxesForShareBasedCompensationAndProceedsFromExerciseOfStockOptions
498000
CY2020 mnkd Payments Related To Employment Taxes For Share Based Compensation And Proceeds From Exercise Of Stock Options
PaymentsRelatedToEmploymentTaxesForShareBasedCompensationAndProceedsFromExerciseOfStockOptions
-233000
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
106000
CY2020 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
215000
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
11600000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
10000000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
4873000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
270267000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49853000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
57021000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
36941000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124200000
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
79900000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
56600000
CY2021Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
230000000.0
CY2021Q1 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.0250
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.25%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Financial Statement Estimates<span style="font-style:normal;"> — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process and the COVID-19 pandemic has increased the level of judgment used by management in developing these estimates and assumptions. The COVID-19 pandemic continues to rapidly evolve and the ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. These effects could have a material impact on the estimates and assumptions used in the preparation of the accompanying consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, milestone rights liability, stock-based compensation and the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, and the valuation allowance recorded against net deferred tax assets. </span></p>
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
124184000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67005000
CY2020Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
158000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
500000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0
CY2021Q4 us-gaap Debt Securities Held To Maturity Allowance For Credit Loss
DebtSecuritiesHeldToMaturityAllowanceForCreditLoss
0
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
103669000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
59495000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Within One Year Fair Value
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
59495000
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
56619000
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
56433000
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
160352000
CY2021Q4 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
160102000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis
59495000
CY2020Q4 us-gaap Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value
HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue
59495000
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<span style="font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</span><span style="font-style:normal;"> — Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents</span><span style="font-style:normal;"> and investments</span><span style="font-style:normal;">. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consist of interest-bearing money market accounts and U.S. </span><span style="font-style:normal;">Treasury securities with maturities less than 90 days. Investments generally consist of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.</span>
CY2021Q4 mnkd Accounts Receivable Other
AccountsReceivableOther
255000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4994000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4218000
CY2021 mnkd Number Of Wholesale Distributors
NumberOfWholesaleDistributors
3
CY2021 mnkd Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
0.80
CY2020 mnkd Percentage Of Sales From Major Customers
PercentageOfSalesFromMajorCustomers
0.86
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
800000
CY2021 mnkd Percentage Of Sales From Major Customers Collaborations And Services
PercentageOfSalesFromMajorCustomersCollaborationsAndServices
0.95
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
958000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27419000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1393000
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2522000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2484000
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
100000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
19707000
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1927000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1096000
CY2021Q4 us-gaap Inventory Net
InventoryNet
7152000
CY2020Q4 us-gaap Inventory Net
InventoryNet
4973000
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
2703000
CY2021 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
1900000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
14022000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
11250000
CY2021Q4 mnkd Customer Discounts And Allowances
CustomerDiscountsAndAllowances
4227000
CY2020 us-gaap Production Related Impairments Or Charges
ProductionRelatedImpairmentsOrCharges
500000
CY2020Q4 mnkd Customer Discounts And Allowances
CustomerDiscountsAndAllowances
3688000
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2166000
CY2021Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1380000
CY2020Q4 us-gaap Direct Financing Lease Deferred Selling Profit
DirectFinancingLeaseDeferredSellingProfit
1422000
CY2021Q4 mnkd Current Portion Of Milestone Right Liability
CurrentPortionOfMilestoneRightLiability
1088000
CY2020Q4 mnkd Current Portion Of Milestone Right Liability
CurrentPortionOfMilestoneRightLiability
1337000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
895000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
533000
CY2021Q4 mnkd Retail Inventory Purchase
RetailInventoryPurchase
-875000
CY2021Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
786000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1980000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
134273000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
122687000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
97661000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
96820000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36612000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25867000
CY2021 us-gaap Depreciation
Depreciation
2000000.0
CY2021Q4 us-gaap Senior Notes
SeniorNotes
223944000
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
18425000
CY2020Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
63027000
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
281202000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
122235000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
6667000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
20000000
CY2021Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
31758000
CY2021Q4 mnkd Long Term Debt Maturities Repayments Of Principal After Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearThree
230000000
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
288425000
CY2021Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1167000
CY2021Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
6056000
CY2021 us-gaap Debt Instrument Frequency Of Periodic Payment
DebtInstrumentFrequencyOfPeriodicPayment
Principal on each term loan advance under Tranche 1, Tranche 2 and, if applicable, Tranche 3 is payable in 24 equal monthly installments beginning September 1, 2023, until paid in full on August 1, 2025.
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
281202000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34937000
CY2019Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-11-03
CY2021 mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
377000
CY2020 mnkd Amortization Of Debt Discount
AmortizationOfDebtDiscount
268000
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1215000
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
101000
CY2021Q4 mnkd Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
5900000
CY2020Q4 mnkd Milestone Rights Liabilities Current And Noncurrent
MilestoneRightsLiabilitiesCurrentAndNoncurrent
7300000
CY2020 mnkd Payment For Milestone Rights Liabilities
PaymentForMilestoneRightsLiabilities
5000000.0
CY2021Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2025-12-31
CY2021Q4 mnkd Milestone Rights Liability Current
MilestoneRightsLiabilityCurrent
1300000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
40847000
CY2021 mnkd Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
21707000
CY2020 mnkd Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
1910000
CY2020 mnkd Contract With Customer Liability Upfront And Milestone Payments
ContractWithCustomerLiabilityUpfrontAndMilestonePayments
25000000
CY2021 mnkd Contract With Customer Liability Collaborations And Services Revenue
ContractWithCustomerLiabilityCollaborationsAndServicesRevenue
-36274000
CY2020 mnkd Contract With Customer Liability Collaborations And Services Revenue
ContractWithCustomerLiabilityCollaborationsAndServicesRevenue
-32820000
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20370000
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34937000
CY2021Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
50900000
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
5000000.0
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7000000.0
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
93500000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
251477562
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
251477562
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
242117089
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
242117089
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
100000
CY2021 mnkd Market Price Stock Purchase Plan
MarketPriceStockPurchasePlan
25000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-80926000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-57240000
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
249244000
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
222585000
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.32
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.26
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
69998009
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
32745273
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10655146
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7609025
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5344810
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12200000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6511000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.41
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
15414000
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
586572
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.72
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
258410
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.59
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
764488
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
11.57
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
10655146
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.96
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
25458000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
8009961
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
3.40
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
18436000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
970000
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2300000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4500000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1700000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
500000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000.0
CY2021 mnkd Interest Expense On Financing Liability
InterestExpenseOnFinancingLiability
1373000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6037542
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
2.20
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
3326798
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.82
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
1516065
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
2.22
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
239250
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
2.58
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7609025
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
3.77
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
2500000
CY2020Q4 mnkd Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding
13300000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
100500000
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
93500000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
7000000.0
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.090
CY2021Q4 mnkd Finance Lease Liability Discounted Payments Due Next Twelve Months
FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths
6373000
CY2021Q4 mnkd Finance Lease Liability Discounted Payments Due Year Two
FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo
9778000
CY2021Q4 mnkd Finance Lease Liability Discounted Payments Due Year Three
FinanceLeaseLiabilityDiscountedPaymentsDueYearThree
10023000
CY2021Q4 mnkd Finance Lease Liability Discounted Payments Due Year Four
FinanceLeaseLiabilityDiscountedPaymentsDueYearFour
10274000
CY2021Q4 mnkd Finance Lease Liability Discounted Payments Due Year Five
FinanceLeaseLiabilityDiscountedPaymentsDueYearFive
10539000
CY2021Q4 mnkd Finance Lease Liability Discounted Payments Due After Year Five
FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive
199091000
CY2021Q4 mnkd Finance Lease Liability Discounted Payments Due
FinanceLeaseLiabilityDiscountedPaymentsDue
246078000
CY2021Q4 mnkd Finance Lease Liability Discounted Excess Amount
FinanceLeaseLiabilityDiscountedExcessAmount
142485000
CY2021Q4 mnkd Finance Lease Liability Discounted Debt Issuance Costs
FinanceLeaseLiabilityDiscountedDebtIssuanceCosts
3091000
CY2021Q4 mnkd Finance Lease Liability Discounted
FinanceLeaseLiabilityDiscounted
100502000
CY2021 mnkd Payment Of Long Term Purchase Commitment Amendment Fee
PaymentOfLongTermPurchaseCommitmentAmendmentFee
2000000.0
CY2021Q4 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
5400000
CY2021Q1 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
7000000.0
CY2021Q4 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
8800000
CY2021Q1 us-gaap Purchase Obligation Due In Second Year
PurchaseObligationDueInSecondYear
8500000
CY2021Q4 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
14600000
CY2021Q1 us-gaap Purchase Obligation Due In Third Year
PurchaseObligationDueInThirdYear
10900000
CY2021Q4 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
15500000
CY2021Q1 us-gaap Purchase Obligation Due In Fourth Year
PurchaseObligationDueInFourthYear
14600000
CY2021Q4 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
19400000
CY2021Q1 us-gaap Purchase Obligation Due In Fifth Year
PurchaseObligationDueInFifthYear
15500000
CY2021Q4 mnkd Purchase Obligation Due In Sixth Year
PurchaseObligationDueInSixthYear
9200000
CY2021Q1 mnkd Purchase Obligation Due In Sixth Year
PurchaseObligationDueInSixthYear
19400000
CY2021 mnkd Long Term Purchase Commitment Expiration Date
LongTermPurchaseCommitmentExpirationDate
2027-12-31
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.073
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.075
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
863000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1403000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
515000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
394000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1867000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
1797000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
79455000
CY2020Q4 mnkd Deferred Tax Assets Tax Deferred Expense Accrual Adjustment
DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment
1436000
CY2021Q4 mnkd Deferred Tax Assets Loss On Purchase Commitment
DeferredTaxAssetsLossOnPurchaseCommitment
24845000
CY2021 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
1500000
CY2020 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
900000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-4377000
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-14461000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-469000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-19631000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4846000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-19631000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4846000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
542800000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
533448000
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-80926000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-57458000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-80926000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-57458000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
-218000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-218000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5170000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
78804000
CY2021Q4 mnkd Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
1440000
CY2020Q4 mnkd Deferred Tax Assets Milestone Rights
DeferredTaxAssetsMilestoneRights
1547000
CY2021Q4 mnkd Deferred Tax Assets Tax Deferred Expense Accrual Adjustment
DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment
2591000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3766000
CY2020Q4 mnkd Deferred Tax Assets Loss On Purchase Commitment
DeferredTaxAssetsLossOnPurchaseCommitment
23864000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5684000
CY2021Q4 mnkd Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
7518000
CY2020Q4 mnkd Deferred Tax Assets Capitalized Costs
DeferredTaxAssetsCapitalizedCosts
5273000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
2568000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Other
DeferredTaxAssetsTaxDeferredExpenseOther
2093000
CY2021Q4 mnkd Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
588000
CY2020Q4 mnkd Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
559000
CY2021Q4 mnkd Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
5696000
CY2020Q4 mnkd Deferred Tax Assets Interest Expense Limitation
DeferredTaxAssetsInterestExpenseLimitation
2460000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
22983000
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
20735000
CY2021Q4 mnkd Deferred Tax Assets Product Revenue And Costs
DeferredTaxAssetsProductRevenueAndCosts
404000
CY2020Q4 mnkd Deferred Tax Assets Product Revenue And Costs
DeferredTaxAssetsProductRevenueAndCosts
1569000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
695921000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
676205000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
695094000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
675463000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
827000
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
742000
CY2021Q4 mnkd Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
555000
CY2020Q4 mnkd Deferred Tax Liabilities Right Of Use Asset
DeferredTaxLiabilitiesRightOfUseAsset
510000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
272000
CY2020Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
232000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
827000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
742000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.044
CY2020 mnkd Effective Income Tax Rate Reconciliation Permanent Items
EffectiveIncomeTaxRateReconciliationPermanentItems
-0.061
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.003
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.005
CY2021 mnkd Effective Income Tax Rate Reconciliation Expirations Of Attribute
EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
-0.059
CY2020 mnkd Effective Income Tax Rate Reconciliation Expirations Of Attribute
EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute
-0.066
CY2021 mnkd Effective Income Tax Rate Reconciliation Foreign Withholding Tax
EffectiveIncomeTaxRateReconciliationForeignWithholdingTax
0.000
CY2020 mnkd Effective Income Tax Rate Reconciliation Foreign Withholding Tax
EffectiveIncomeTaxRateReconciliationForeignWithholdingTax
0.004
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.112
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.078
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.000
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.004
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
695100000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-19600000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-4800000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
2200000000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
1300000000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration
DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
452700000
CY2021 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Pursuant to IRC Sections 382 and 383, annual use of the Company’s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.
CY2004Q3 mnkd Operating Loss Carryforwards Subject To Limitation
OperatingLossCarryforwardsSubjectToLimitation
216000000.0
CY2004Q3 mnkd Net Operating Loss Carryforward Annual Limitation
NetOperatingLossCarryforwardAnnualLimitation
13000000.0
CY2021 mnkd Research And Development Credits Begin To Expire
ResearchAndDevelopmentCreditsBeginToExpire
2021
CY2021Q4 mnkd Deferred Tax Assets Tax Credit Carryforwards Research Expire
DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire
1200000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
268902000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
268902000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
268902000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
268902000
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0

Files In Submission

Name View Source Status
0001564590-22-006702-index-headers.html Edgar Link pending
0001564590-22-006702-index.html Edgar Link pending
0001564590-22-006702.txt Edgar Link pending
0001564590-22-006702-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mnkd-10k_20211231.htm Edgar Link pending
mnkd-10k_20211231_htm.xml Edgar Link completed
mnkd-20211231.xsd Edgar Link pending
mnkd-20211231_cal.xml Edgar Link unprocessable
mnkd-20211231_def.xml Edgar Link unprocessable
mnkd-20211231_lab.xml Edgar Link unprocessable
mnkd-20211231_pre.xml Edgar Link unprocessable
mnkd-ex231_9.htm Edgar Link pending
mnkd-ex311_10.htm Edgar Link pending
mnkd-ex312_14.htm Edgar Link pending
mnkd-ex321_6.htm Edgar Link pending
mnkd-ex322_11.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending